These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31094090)

  • 41. Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.
    Ikeda K; Kawamura Y; Kobayashi M; Kominami Y; Fujiyama S; Sezaki H; Hosaka T; Akuta N; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
    Dig Dis Sci; 2017 Oct; 62(10):2932-2942. PubMed ID: 28884320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Axl activates autocrine transforming growth factor-β signaling in hepatocellular carcinoma.
    Reichl P; Dengler M; van Zijl F; Huber H; Führlinger G; Reichel C; Sieghart W; Peck-Radosavljevic M; Grubinger M; Mikulits W
    Hepatology; 2015 Mar; 61(3):930-41. PubMed ID: 25251599
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
    Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM
    BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection.
    Choi WM; Lee JH; Ahn H; Cho H; Cho YY; Lee M; Yoo JJ; Cho Y; Lee DH; Lee YB; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS; Kim CY; Lee HS
    Liver Int; 2015 Aug; 35(8):1992-2000. PubMed ID: 25556714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of programmed cell death ligand 1 (PD-L1) for hepatocellular carcinoma: a meta-analysis.
    Li XS; Li JW; Li H; Jiang T
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32255189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of sphingosine kinase 1 on the prognosis of hepatocellular carcinoma patients with portal vein tumor thrombus.
    Shi J; He YY; Sun JX; Guo WX; Li N; Xue J; Cheng SQ
    Ann Hepatol; 2015; 14(2):198-206. PubMed ID: 25671829
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma.
    Li L; Yan J; Xu J; Liu CQ; Zhen ZJ; Chen HW; Ji Y; Wu ZP; Hu JY; Zheng L; Lau WY
    PLoS One; 2014; 9(10):e110064. PubMed ID: 25303284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preoperative predictors of short-term survival after hepatectomy for multinodular hepatocellular carcinoma.
    Zhao WC; Zhang HB; Yang N; Fu Y; Qian W; Chen BD; Fan LF; Yang GS
    World J Gastroenterol; 2012 Jul; 18(25):3272-81. PubMed ID: 22783052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment Optimization for Hepatocellular Carcinoma in Elderly Patients in a Japanese Nationwide Cohort.
    Kaibori M; Yoshii K; Hasegawa K; Ogawa A; Kubo S; Tateishi R; Izumi N; Kadoya M; Kudo M; Kumada T; Sakamoto M; Nakashima O; Matsuyama Y; Takayama T; Kokudo N;
    Ann Surg; 2019 Jul; 270(1):121-130. PubMed ID: 29608544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy: a retrospective study of 601 Chinese patients.
    Zhang TT; Zhao XQ; Liu Z; Mao ZY; Bai L
    Clin Transl Oncol; 2016 Aug; 18(8):831-40. PubMed ID: 26577107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postoperative Albumin-Bilirubin Grade Change Predicts the Prognosis of Patients with Hepatitis B-Related Hepatocellular Carcinoma Within the Milan Criteria.
    Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ
    World J Surg; 2018 Jun; 42(6):1841-1847. PubMed ID: 29138913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes after hepatic resection and subsequent multimodal treatment of recurrence for multifocal hepatocellular carcinoma.
    Kim PT; Jang JH; Atenafu EG; Fischer S; Greig PD; McGilvray ID; Wei AC; Gallinger S; Cleary SP
    Br J Surg; 2013 Oct; 100(11):1516-22. PubMed ID: 24037575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].
    Li CX; Zhang H; Wu XF; Han S; Jiao CY; Wang D; Wang K; Li XC
    Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):134-143. PubMed ID: 33378806
    [No Abstract]   [Full Text] [Related]  

  • 55. Inhibition of HIF1A-AS1 promoted starvation-induced hepatocellular carcinoma cell apoptosis by reducing HIF-1α/mTOR-mediated autophagy.
    Hong F; Gao Y; Li Y; Zheng L; Xu F; Li X
    World J Surg Oncol; 2020 May; 18(1):113. PubMed ID: 32473641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognosis of Early-Stage Hepatocellular Carcinoma: The Clinical Implications of Substages of Barcelona Clinic Liver Cancer System Based on a Cohort of 1265 Patients.
    Kao WY; Chao Y; Chang CC; Li CP; Su CW; Huo TI; Huang YH; Chang YJ; Lin HC; Wu JC
    Medicine (Baltimore); 2015 Oct; 94(43):e1929. PubMed ID: 26512620
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study.
    Liu J; Zhu Q; Li Y; Qiao GL; Xu C; Guo DL; Tang J; Duan R
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):330-338. PubMed ID: 29551612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma.
    Wu DH; Jia CC; Chen J; Lin ZX; Ruan DY; Li X; Lin Q; Min-Dong ; Ma XK; Wan XB; Cheng N; Chen ZH; Xing YF; Wu XY; Wen JY
    Tumour Biol; 2014 Dec; 35(12):12225-33. PubMed ID: 25256671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Repeat treatment for recurrent hepatocellular carcinoma: is it validated?
    Kishi Y; Saiura A; Yamamoto J; Koga R; Seki M; Morimura R; Yoshioka R; Kokudo N; Yamaguchi T
    Langenbecks Arch Surg; 2011 Oct; 396(7):1093-100. PubMed ID: 21847622
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
    Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
    Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.